| Target Price | $3.06 |
| Price | $1.61 |
| Potential |
90.06%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target OPKO Health, Inc. 2027 .
The average OPKO Health, Inc. target price is $3.06.
This is
90.06%
register free of charge
$8.93
454.35%
register free of charge
$3.03
88.20%
register free of charge
|
|
| A rating was issued by 10 analysts: 7 Analysts recommend OPKO Health, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2027 of
90.06%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 606.88 | 575.59 |
| 14.90% | 5.16% | |
| EBITDA Margin | -23.25% | -9.23% |
| 13.15% | 60.30% | |
| Net Margin | -37.19% | -28.53% |
| 398.30% | 23.28% |
7 Analysts have issued a sales forecast OPKO Health, Inc. 2026 . The average OPKO Health, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2026. The average OPKO Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 OPKO Health, Inc. Analysts have issued a net profit forecast 2026. The average OPKO Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.30 | -0.22 |
| 275.00% | 26.67% | |
| P/E | negative | |
| EV/Sales | 2.18 |
7 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
OPKO Health, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barrington Research |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | May 01 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barrington Research:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 25 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


